Inhibition of precursor B cell malignancy progression by toll-like receptor ligand-induced immune responses

Ítems similars

• Differential Depletion of Bone Marrow Resident B-ALL after Systemic Administration of Endosomal TLR Agonists
  per: Jo, Sumin, et al.
  Publicat: (2020)
• Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses
  per: Seif, Alix E., et al.
  Publicat: (2009)
• Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease
  per: Brown, Valerie I., et al.
  Publicat: (2008)
• Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling
  per: Barrett, David M., et al.
  Publicat: (2011)
• Deciphering the DNA damage histone code: Comment on: Xie A, et al. Cell Cycle 2010; 9:3602–10
  per: DeMicco, Amy, et al.
  Publicat: (2010)